Joseph C. Cappelleri, PhD

Pfizer Inc.

Disclosure(s): Pfizer Inc.: Employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-674) The Economic Burden of Infant RSV Among US Caregivers
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1977) Six-Month Trajectory of Symptoms of COVID-19 Fatigue by Age and BNT162b2 COVID-19 Vaccination Status: A Prospective Study among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-2017) Patient Reported Outcomes of Nirmatrelvir/Ritonavir Treatment for High-risk, Nonhospitalized Adults with Symptomatic COVID-19
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-2060) Effectiveness of BNT162b2 COVID-19 Vaccination Against Long COVID Among Older Adults: A Nationwide Study
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT